Centene Corporation (NYSE:CNC – Get Free Report) has been given a consensus recommendation of “Hold” by the twenty analysts that are covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a sell recommendation, fourteen have given a hold recommendation and three have given a buy recommendation to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $38.4375.
Several research firms recently commented on CNC. Zacks Research upgraded shares of Centene from a “strong sell” rating to a “hold” rating in a research note on Wednesday, October 29th. Barclays set a $44.00 price target on Centene and gave the stock an “equal weight” rating in a research report on Tuesday, November 4th. The Goldman Sachs Group reissued a “sell” rating and issued a $38.00 price objective (up previously from $33.00) on shares of Centene in a research report on Thursday, October 30th. Morgan Stanley upped their target price on Centene from $28.00 to $38.00 and gave the company an “equal weight” rating in a research report on Tuesday, October 14th. Finally, Wells Fargo & Company lowered their price target on Centene from $41.00 to $35.00 and set an “equal weight” rating for the company in a report on Wednesday, November 12th.
Check Out Our Latest Research Report on CNC
Institutional Inflows and Outflows
Centene Stock Up 1.6%
Shares of NYSE CNC opened at $40.52 on Wednesday. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.83. The stock has a market capitalization of $19.92 billion, a PE ratio of -3.75, a price-to-earnings-growth ratio of 1.35 and a beta of 0.47. Centene has a 12-month low of $25.08 and a 12-month high of $66.81. The stock’s fifty day simple moving average is $37.46 and its two-hundred day simple moving average is $35.59.
Centene (NYSE:CNC – Get Free Report) last posted its earnings results on Wednesday, October 29th. The company reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.71. The company had revenue of $49.69 billion for the quarter, compared to analyst estimates of $47.50 billion. Centene had a positive return on equity of 7.82% and a negative net margin of 2.85%.The firm’s quarterly revenue was up 18.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.62 earnings per share. As a group, analysts expect that Centene will post 6.86 EPS for the current fiscal year.
About Centene
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Featured Articles
- Five stocks we like better than Centene
- Do not delete, read immediately
- How the Rich Retire
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- How Long Will $1M Last in Retirement?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
